TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by 3M Company to registration of trade mark application 1290768 (1, 3, 5) - AVATAR - in the name of Sash Cacoroski.
| Delegate: | Aaron Walters |
| Representation: | Opponent: Written submissions by Davies Collison Cave Trade Mark and Patent Attorneys Applicant: No submissions |
| Decision: | 2018 ATMO 97 Trade Marks Act 1995 (Cth) - section 44 – identical trade marks – similar goods – registration refused. |
Background
On 22 March 2009, Sash Cacoroski (‘the Applicant’) filed an application for the following trade mark:
Application number: 1290768
Trade Mark: AVATAR (‘the Trade Mark’)
Filing Date: 22 March 2009
In respect of the following goods (‘the claimed goods’):
Class 1:
Ingredients for skin care preparations
Class 3:
Cosmetic preparations for skin care; Cosmetic products for skin care; Cosmetic skin care products; Essences for skin care; Non-medicated products for skin care; Non-medicated skin care beauty products; Non-medicated skin care products; Powders for skin care (not for medical use); Skin care creams (cosmetic); Skin care lotions (cosmetic); Skin care oils (cosmetic); Skin care preparations (cosmetic); Skin care products (cosmetic); Sun skin care products (cosmetics)
Class 5:
Medicated skin care preparations; Pharmaceutical preparations for skin care; Powders for skin care (for medical use); Skin care creams for medical use; Skin care lotions (medicated); Skin care oils (medicated); Skin care preparations (medicated); Skin care products (medicated); Sun skin care products for medical purposes
The Trade Mark was examined as required under s 31 of the Trade Marks Act 1995 (Cth) (‘the Act’), and advertised as having been accepted for possible registration in the Australian Official Journal of Trade Marks on 16 July 2009.
On 14 January 2010, 3M Company (‘the Opponent’) filed a Notice of Opposition to the registration of the Trade Mark nominating grounds of opposition under ss 41, 42(b), 43, 44, 58, 59, 60, 62(b) and 62A of the Act.[1] The Opponent filed its Evidence in Support on 13 July 2010. The Applicant did not file any evidence.
[1] Prior to the to the Act’s 2013 ‘Raising the Bar’ amendments, it was not necessary for the Opponent to particularise grounds of oppositions in their Notice of Opposition.
On 9 August 2011 a request to be heard was made by the Opponent, with the matter set for hearing on 14 February 2012. However, in response to correspondence received 6 February 2012, the Registrar granted a deferment of the hearing as the parties were negotiating a resolution to the opposition. On 10 June 2014, the Registrar was informed of a breakdown in negotiations between the parties. The matter has remained afoot since this time and on 2 February 2018 this Office sought an update of the status of the opposition from the parties, with the result that the Opponent’s representatives filed submissions.
Accordingly, the Opponent relies on its written submissions from Davies Collison Cave (‘the Opponent’s submissions’) received 23 February 2018. Due to there being no successful contact between IP…
Keep reading for free
Create a free CaseChat account to read 3M Company v Tish & Sash Cacoroski and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] ATMO 97
- Decision Date
CaseChat Overview and Summary
The primary legal issue before the court was whether the applicant's proposed trade mark should be refused registration under section 44 of the *Trade Marks Act 1995* (Cth). This required an assessment of whether the goods for which registration was sought, specifically fungicides, were of the same description as, or similar to, goods in respect of which the opponent held registered trade marks, namely Class 1 goods (ingredients for skin care preparations) and Class 3 goods (cosmetic preparations and products for skin care).
The Delegate reasoned that the composition and function of fungicidal skin care products were critical. Drawing on the High Court's decision in *In Register of Trade Marks v Muller*, the Delegate noted the significance of "active ingredients" in pharmaceutical and medicated products. It was considered common consumer knowledge that the efficacy of such goods derived from an active ingredient, and that other ingredients were present to supplement this. While acknowledging that fungicides might be acquired through different trade channels as either an ingredient or a finished product, the Delegate found that their nature and purpose were such that they ultimately remained "of the same description." This conclusion was supported by the fact that a fungicide is both the ingredient and the product used by a consumer to treat a fungal infection. Furthermore, the Delegate found support for the contention that fungicides are used as ingredients in cosmetics, citing an extract from a Cosmetic Ingredients Reference Guide that identified fungicidal properties in ingredients used in creams, lotions, and mascara.
Consequently, the Delegate found that the opponent had succeeded in establishing the nominated ground of opposition under section 44 of the Act. The application to register the trade mark was refused. The applicant was also ordered to pay the opponent's costs.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
To my mind, a critical aspect of the kind of goods under comparison here, being fungicidal skin care products and the ingredients thereof, concerns their composition and function. The High Court in In Register of Trade Marks v Muller (‘Muller’) said of similar goods: When linked to pharmaceutical products where the quantity and concentration of active ingredients is an important, if not critical, factor, the word makes reference to the character or quality of the product because it will be understood by the public as a representation about its ingredients or its strength.[21] [My emphasis in bold][21] [1980] HCA 35; (1980) 144 CLR 37, [10]. Although Muller was concerned with the distinctiveness of the word LESS in regards to pharmaceutical products, the High Court recognized the significance of “active ingredients” to goods of a pharmaceutical nature. I find it to be common consumer knowledge that the use or function of such goods, intended to treat an ailment or infection, will be derived from an “active ingredient”. A consumer will also be aware such goods are comprised of multiple ingredients intended to supplement the “active ingredient”. This is due, in general, to an understanding that such ingredients, in their raw or undiluted form, may be harmful in application to a consumer. As such, diverging trade channels may occur through which a fungicide, being a medicated skin care product, is made available to the consumer, as opposed to its fungicidal component ingredient. However, this is not, in and of itself, determinative of whether goods are “of the same description”. Goods need not be substitutes of each other and whether they are similar is to be judged from a commercial perspective.[22] [22] Supra., 12. In Reckitt & Colman, the use to which the two sets of goods are to be put is to be considered.[23] The class 1 goods are ingredients intended specifically for skin care preparations. This would accordingly include fungicidal ingredients intended for skin care. As alluded to earlier, a consumer will seek out and use goods intended to treat a fungal skin infection based on the “active ingredient”, in this instance a fungicide. In this way, I consider the use for which the goods to be put is the same, as a fungicide is both the ingredient and product used by a consumer to treat a fungal infection. While the goods may be acquired at different stages, their nature and purpose are such that they ultimately remain “of the same description”. Consequently, I accept a fungicide is similar to the class 1 goods. [23] Supra., 11. Turning to the class 3 goods, Mr Sprague asserts the ingredients and composition of fungicides is similar to that of “certain goods” listed under the Trade Mark.[24] The Opponent’s submissions clarify this, in relation to the class 3 goods, to mean fungicides are of the same description as the broad claims for cosmetic preparations and products for skin care. [24] Supra., 14. In support, Sprague contains Exhibit C featuring an extract of the Cosmetic Ingredients Reference Guide and Dictionary (accessed 20 May 2010 at This extract lists a large number of ingredients alongside their definitions, of which I was able to identify two as having fungicidal properties. These are Dibromosalan, being a fungicide used in inter alia, creams and lotions, and Phenylmercuric acetate, a preservative fungicide used in mascara. Accordingly, Exhibit C supports the Opponent’s contention that fungicides are used as ingredients in cosmetics.